[{"AccountsPayableCurrent_0_Q3_USD":183911.0,"ProductionTaxExpense_1_Q3_USD":50411.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":150000.0,"ProceedsFromIssuanceOfPrivatePlacement_3_Q3_USD":6025000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":201250000.0,"PrepaidExpenseCurrent_0_Q3_USD":522202.0,"PreferredStockValue_0_Q3_USD":null,"ProductionTaxExpense_3_Q3_USD":149723.0,"PreferredStockSharesOutstanding_0_Q3_shares":null,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsForRent_3_Q3_USD":10000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":201250000.0,"OtherIntangibleAssetsNet_0_Q3_USD":5000001.0,"OperatingIncomeLoss_3_Q3_USD":-3564208.0,"PreferredStockSharesIssued_0_Q3_shares":null,"OperatingIncomeLoss_1_Q3_USD":-1222990.0,"ProfitLoss_1_Q3_USD":-1217917.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":200000.0,"TemporaryEquityRedemptionPricePerShare_0_Q3_USD":10.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":201250000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_3_Q3_USD":-11455480.0,"TemporaryEquityAccretionToRedemptionValue_3_Q3_USD":11455480.0,"TaxesPayableCurrent_0_Q3_USD":149091.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":5000001.0,"StockholdersEquity_0_Q3_USD":-8958534.0,"SharePrice_0_Q3_USD":10.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":80000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":30000.0,"SaleOfStockConsiderationReceivedOnTransaction_3_Q3_USD":201300000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-8959097.0,"RestrictedInvestmentsPercentOfNetAssets_0_Q3_pure":0.2,"SharesIssuedPricePerShare_0_Q3_USD":10.0,"NotesPayableCurrent_0_Q3_USD":null,"NetIncomeLoss_3_Q3_USD":-3552022.0,"NetIncomeLoss_1_Q3_USD":-1217917.0,"DebtInstrumentFeeAmount_0_Q3_USD":200000.0,"CumulativeEarningsDeficit_0_Q3_USD":1800000.0,"CommonStockValue_0_Q3_USD":60.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":48000.0,"DeferredCosts_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":39530.0,"Cash_0_Q3_USD":48330.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":201262186.0,"AssetsCurrent_0_Q3_USD":570532.0,"Assets_0_Q3_USD":201832718.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":2164500.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":48330.0,"DeferredIncomeNoncurrent_0_Q3_USD":7043750.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.05,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.16,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1759940.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-201250000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":203049470.0,"LiabilitiesCurrent_0_Q3_USD":2497502.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":201832718.0,"Liabilities_0_Q3_USD":9541252.0,"InterestIncomeOther_3_Q3_USD":12186.0,"InterestIncomeOther_1_Q3_USD":5073.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":522202.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2119500.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":57879.0,"GeneralAndAdministrativeExpense_3_Q3_USD":3334485.0,"GeneralAndAdministrativeExpense_1_Q3_USD":1142579.0,"GainLossOnInvestments_3_Q3_USD":12186.0,"EquityMethodInvestmentOwnershipPercentage_0_Q3_pure":0.5,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":20727500.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":17083104.0,"Ticker":"PRDS","CIK":"1822711","name":"FS DEVELOPMENT CORP. II","OfficialName":"Pardes Biosciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"505269868.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]